Clinical Update 2025: Recommendations on the Use of Antidepressants in Women Taking Tamoxifen
While some antidepressants may affect the metabolism of tamoxifen into its active form, many antidepressants can be used safely in this population.
Beyond the FDA Panel: Medical Experts Reaffirm the Safety and Essential Role of SSRIs for Perinatal Mental Health
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; however, medical organizations and experts support the important role of SSRIs and other medications in supporting maternal mental health.
Marlene Freeman, MD: Getting to the Truth About SSRIs and Pregnancy (Video)
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; Dr. Freeman weighs in on the information provided in the report.
Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
Weighing the Evidence: Response to the FDA’s Recent Panel on Antidepressant Use in Pregnancy.
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
Using AI and Data from the Medical Record to Identify Individuals at Risk for Postpartum Depression
In a recent study from Mass General Hospital, researchers examined whether information included in the medical record at the time of discharge after delivery could help us to identify individuals at increased risk for postpartum depression.
Postpartum Depression with Comorbid Anxiety: Optimizing Treatment
Postpartum anxiety is a common and often under-recognized condition that affects a substantial proportion of new mothers.
Risk of Malformations in Children with Prenatal Exposure to Antidepressants and Benzodiazepines
This large cohort study from Taiwan indicates that the concomitant use of antidepressants and benzodiazepines during the first trimester is not associated with a substantial increase in risk for overall malformations.
Do SSRI Antidepressants Lower Risk of Preeclampsia? Maybe, But It’s Complicated
There is evidence that depression itself can increase risk for preeclampsia. In women with more severe depression, treatment with an SSRI antidepressant may decrease risk.
Treatment of PPD with SSRIs: Long-Term Benefits for Both Mother and Child
Postpartum SSRI treatment mitigated the negative associations between PPD and later maternal depression, partner relationship satisfaction, and child externalizing problems and ADHD symptoms up to 5 years after childbirth.